| | Author | Mao et al. [9] | De Rojas et al. [10] | Davies and Pineda [16] | Chan et al. [11] | Yoshida et al. [8] | Nakamura et al. [19] | Dikopf et al. [12] |
| | Year | 2018 | 2017 | 2017 | 2017 | 2015 | 2015 | 2013 | | Number | 109 eyes | 19 eyes | 30 eyes | 67 eyes | 56 eyes | 58 eyes | 80 eyes | | Surgery age (years) mean ± SD | 53.4 ± 10.3 | 51 ± 13 | 52.4 ± 13.7 | 59.2 ± 12.3 | 62.6 ± 10.4 | 29–83 (range) | 48.9 (mean) | | Mean follow-up time | 3 months | 259 days (median) | 3.7 ± 3.3 months | 6.9 ± 4.4 years | 37.5 ± 22.6 months | 3 months | 23.3 months | | Baseline BCVA (log MAR) mean ± SD | 0.8 ± 0.59 | 0.33 ± 0.20 | 1.09 ± 0.69 | 1.27 ± 0.42 | 0.76 ± 0.65 | 0.81 ± 0.51 | 1.23 ± 0.99 | | Postoperative BCVA (log MAR) mean ± SD | 0.45 ± 0.41 (final) | 0.19 ± 0.17 (final) | 0.61 ± 0.45 (1 month) | 0.92 ± 0.49 (3 months) 0.97 ± 0.53 (1 year) 1.18 ± 0.49 (final) | 0.42 ± 0.55 (6 months) 0.45 ± 0.53 (final) | 0.34 ± 0.43 (final) | 0.81 ± 0.87 (3 months) | | Change in final BCVA (log MAR) | 0.35 | 0.14 | NA | 0.09 | 0.31 | 0.47 | NA | | Improved VA | 52/109, 47.7% | 17/19, 89.0% | 29/3., 96.7% | 30/67, 44.8% | 26/56, 46.4% | 37/58, 63.8% | 70/80, 87.5% | | Unchanged VA | 57/109, 52.3% | 2/19, 11.0% | 1/30, 3.3% | 37/67, 55.2% | 30/56, 53.6% | 21/58, 36.2% | 8/80, 10.0% | | Worsened VA | 0% | 0% | 0% | | 0% | 0% | 2/80, 2.5% | | Complication | NA | PCME (6/19, 32%) PCO (18/19, 95%) | PCME (4/30, 13.3%) PCO (20/30, 66.7%) nd: YAG laser capsulotomy (5/30, 16.7%) | NA | PCO (47/56, 83.9%) Nd: YAG laser capsulotomy (23/56, 41.1%) CCS (13/56, 23.2%) | None | PCO (66/80, 82.5%) YAG laser capsulotomy (42/80, 52.5%) IOL dislocation (2/80, 2.5%) |
|
|
